跳至主要内容
临床试验/NCT04696900
NCT04696900Unknown不适用

Examination of the Effect of Prescribed Cardiac Rehabilitation on Quality of Life, Exercise Capacity and Course of Disease in Patients With Advanced Heart Failure or After Ventricular Assist Device Implantation

German Heart Institute2 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2020年6月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
14
试验地点
2
主要终点
Efficacy of exercise training in severe heart failure as assessed by exercise capacity

研究概览

简要总结

This trial will evaluate the effect of prescribed exercise training on quality of life and exercise capacity of patients with advanced heart failure or after ventricular assist device implantation. Furthermore, clinical, laboratory and echocardiographic markers of heart failure, rehospitalization rates and cost-effectiveness will be assessed.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age >17 years
  • written informed consent
  • chronic end-stage systolic heart failure with or without ventricular assist device
  • clinically stable for at least 6 weeks
  • prescription of cardiac rehabilitation

排除标准

  • addictions or other illnesses that impact the ability to understand the nature, scope and consequences of the trial
  • lack of knowledge of German to fully understand study information
  • pregnancy, pre-menopausal women
  • participation in the rehabilitation program < 80%
  • contraindications of cardiopulmonary exercise testing on an ergometer

结局指标

主要结局

Efficacy of exercise training in severe heart failure as assessed by exercise capacity

时间窗: after 3, 6 and 12 months

Change of exercise capacity measured by six-minute walking distance in meters

Efficacy of exercise training in severe heart failure as assessed by quality of life

时间窗: after 3, 6 and 12 months

Change of quality of life by Kansas City Cardiomyopathy Questionnaire

次要结局

  • Renal function biomarkers: glomerular Filtration rate(after 6 and 12 months)
  • Hepatic function biomarkers: transaminases(after 6 and 12 months)
  • heart failure biomarkers(after 6 and 12 months)
  • Renal function biomarker: Creatinin(after 6 and 12 months)
  • Hepatic function biomarkers: gamma-glutamyltransferase(after 6 and 12 months)
  • Heart failure Progression: Ejection fractions(after 6 and 12 months)
  • rehospitalization rates(12 months before training and 12 months while training)
  • Heart failure Progression: Diameters(after 6 and 12 months)
  • Heart failure Progression: Aortic Valve opening(after 6 and 12 months)
  • Heart failure Progression: Valvular regurgitations(after 6 and 12 months)

研究者

发起方
German Heart Institute
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验